Shekel Brainweigh Ltd. specializes in advanced weighing solutions and smart scales, primarily targeting the healthcare and retail sectors. The company's innovative technology, particularly in digital weighing systems, positions it favorably in a niche market where precision and reliability are critical.
Shekel Brainweigh generates revenue through the sale of high-precision weighing equipment and digital solutions, leveraging its proprietary technology to maintain pricing power. The company benefits from a strong reputation for quality and innovation, which helps to differentiate its products in a competitive landscape.
Adoption rates of digital weighing solutions in healthcare settings
Regulatory changes impacting healthcare equipment standards
Market expansion into emerging economies
Technological advancements in weighing technology
Technological disruption from competitors offering superior weighing solutions
Regulatory changes affecting product compliance and market access
Emerging competitors in the digital weighing space
Price competition from low-cost manufacturers
Negative operating margins leading to cash flow challenges
Potential liquidity issues given the current current ratio of 0.46
moderate - The company's performance is somewhat tied to healthcare spending and retail activity, which can fluctuate with economic cycles.
Interest rates affect the company's financing costs for R&D and capital expenditures, potentially impacting its growth initiatives.
minimal - The company operates with a negative debt/equity ratio, indicating low reliance on external financing.
growth - Investors may be drawn to the potential for expansion in healthcare and retail sectors.
high - The stock has demonstrated significant price fluctuations, particularly with a 1-year return of -70%.